Global Mitral Valve Disease Market Projected to Expand at 9.2% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Mitral Valve Disease Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The mitral valve disease market has experienced significant expansion in recent years. It is anticipated to increase from $3 billion in 2024 to $3.28 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.1%. The growth observed in the past can be credited to patient education initiatives, effective reimbursement policies and insurance coverage, rising healthcare expenditure, enhanced awareness and screening efforts, and an expanding market presence.

The mitral valve disease market size is anticipated to experience robust expansion over the coming years. It is projected to grow to $4.65 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 9.2%. This growth throughout the forecast period can be attributed to the rising prevalence of mitral valve disease, increased adoption of minimally invasive techniques, significant innovations in heart valve surgery, a rise in venture capital investments, and growing interest from manufacturers. Prominent trends for the forecast period include overall technological advancements, specific advancements in transcatheter technologies, and increasingly sophisticated technological improvements in surgical procedures.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

Which Factors And Drivers Are Influencing The Mitral Valve Disease Market In 2025?

The growing incidence of vascular heart diseases is projected to stimulate the expansion of the mitral valve disease market moving forward. Vascular heart diseases refer to a variety of medical conditions that affect the heart’s blood vessels or the heart’s internal structures. An intricate mix of lifestyle choices, demographic shifts, health conditions, environmental influences, and genetic components contributes to the rising cases of vascular heart diseases. These conditions, including ischemic heart disease and hypertension, can indirectly contribute to mitral valve disease by negatively impacting the heart’s structural integrity and functionality, creating circumstances that affect the mitral valve. For instance, in June 2024, data from the Australian Bureau of Statistics 2020-21, based on a National Health Survey conducted by the Australian Institute of Health and Welfare, an Australia-based government agency, showed that in Australia, the death rate from cardiovascular disease among males per 100,000 population increased from 143.7 in 2021 to 148.2 in 2022. Therefore, the escalating prevalence of vascular heart diseases is driving the mitral valve disease market.

What Are The Major Segment Types Covered In The Mitral Valve Disease Market?

The mitral valve diseasemarket covered in this report is segmented –

1) By Treatment Type: Mitral Valve Repair; Mitral Valve Replacement; Cardiac Resynchronization Therapy; Mitral Valve Therapeutics

2) By Indication: Mitral Valve Stenosis; Mitral Valve Prolapse; Mitral Valve Regurgitation

3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users

Subsegments:

1) By Mitral Valve Repair: Surgical Repair; Minimally Invasive Repair; Percutaneous Mitral Valve Repair

2) By Mitral Valve Replacement: Mechanical Valve Replacement; Biological Valve Replacement; Transcatheter Mitral Valve Replacement (TMVR)

3) By Cardiac Resynchronization Therapy: Pacemaker Therapy; Implantable Cardioverter-Defibrillators (ICD); Biventricular Pacing

4) By Mitral Valve Therapeutics: Pharmacological Treatments; Anticoagulation Therapy; Mitral Valve Repair Devices

How Are Trends Influencing The Mitral Valve Disease Market?

Leading firms in the mitral valve disease market are creating stented tissue valves, responding to the increasing need for less invasive therapeutic choices. These valves are engineered to deliver lasting and dependable function, presenting patients with a distinct alternative to conventional surgical procedures. An example of this is Medtronic, an Ireland-based healthcare company, which introduced the Avalus Ultra valve in April 2024. This advanced surgical aortic tissue valve was designed for improved simplicity during its implantation and for effective long-term patient management. Leveraging a decade of clinical insight from the original Avalus valve, the Avalus Ultra incorporates a reduced valve profile for simpler placement, a PEEK base frame to ensure consistent circularity, and an industry-leading Effective Orifice Area (EOA) which has the potential to enhance blood flow. Furthermore, it contains a radiopaque coil, ensuring clear visibility during subsequent valve-in-valve procedures.

Which Global Market Leaders Are Shaping The Future Of The Mitral Valve Disease Sector?

Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

Which Geographies Are Emerging As Strong Markets For The Mitral Valve Disease Industry?

Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Mitral Valve Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16480&type=smp

Browse Through More Reports Similar to the Global Mitral Valve Disease Market 2025, By The Business Research Company

Vacuum Valve Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vacuum-valve-global-market-report

Aerospace Valves Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aerospace-valves-global-market-report

Pigging Valves Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pigging-valves-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795